SLIT: Implementation in Your Practice
  • CE: 1.50
  • CME: 1.25
  • Attendance: 1.25
  • Course opens: Thu, May 01 2014
  • Course expires: Sat, Apr 30 2016
  • Non-member Cost: $0.00

Now that the FDA has approved the first sublingual immunotherapy (SLIT) products for use in the United States, allergist/immunologists have new options to consider when treating their patients who could benefit from allergen immunotherapy. This presentation - a recording of a symposium presented at the 2014 AAAAI Annual Meeting - provides an overview of the mechanisms of SLIT, a summary of the results of clinical trials with these new forms of immunotherapy, and a discussion of how to incorporate the administration of SLIT into an allergy/immunology practice.

Learning objectives

  1. Review how SLIT works.
  2. Discuss the results of pivotal SLIT clinical trials.
  3. Describe how to use SLIT in practice.

Target audience

Allergist/Immunologists

Allied Health Professionals working in allergy/immunology practices

Faculty & credentials

Moderators:

Desiree E.S. Larenas-Linnemann, MD FAAAAI

Michael S. Tankersley, MD FAAAAI

Presenters:

Stephen R. Durham, MA MD FRCP

Thomas B. Casale, MD FAAAAI

Linda Cox, MD FAAAAI
 

Please log in or register to take this Course.

Do you want to enroll in this course?